Legend Biotech Corp (LEGN)

Legend Biotech Corp (LEGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.7B; returns 1 day +2.0%, 1 week +4.3%, 1 year -39.2%.

Legend Biotech is a global biotechnology company focused on developing and manufacturing novel cell therapies, particularly in the field of oncology. Their primary focus is on treating life-threatening diseases with advanced cell therapies.

Groups LEGN belongs to

• Biotechnology
• Oncology
• Biopharmaceutical
• Commercial Stage Biotech
• Healthcare
• Hematologic Malignancies
• Biologics
• Autologous Cell Therapy
• Rare Diseases

LEGN financial model: income statement, cash flow and balance sheet